Naomi Winny Tioline et al. 2026. Effectiveness of Nivolumab and Pembrolizumab as PD-1 Inhibitors in Unresectable or Metastatic Advanced Melanoma: A Systematic Review. KESANS : International Journal of Health and Science. 5, 10 (Jul. 2026), 2027–2038. DOI:https://doi.org/10.54543/kesans.v5i10.692.